SP
MRNA icon

SIH Partners’s Moderna MRNA Stock Holding History

SIH Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Buy
30,844
+3,898
+14% +$202K 0.01% 155
2026
Q1 		$1.37M Buy
+26,946
New +$1.26M 0.02% 163
2025
Q2 		– Sell
-36,846
Closed -$1.04M – 259
2025
Q1 		$1.04M Buy
+36,846
New +$1.31M 0.04% 118

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

SIH Partners's MRNA Position: Q2 2026 in Review

SIH Partners increased its Moderna (MRNA) stake by 14% in Q2 2026, buying an estimated $202K and bringing the position to 30,844 shares worth $2.16M. The position accounts for 0.01% of the portfolio, ranked #155.

SIH Partners first reported a position in MRNA in Q1 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SIH Partners held 30,844 shares of Moderna worth $2.16M as of Q2 2026.
  • SIH Partners bought 3,898 Moderna shares in Q2 2026, an estimated $202K.
  • Moderna made up 0.01% of SIH Partners's portfolio in Q2 2026, its #155 holding.
  • SIH Partners first reported a position in Moderna in Q1 2025 and has held it in 3 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SIH Partners's 13F filing for Q2 2026, filed 14 Aug 2026.